Skip to main content
SpringerLink
Log in

Effect of recombinant human tumor necrosis factor α on the induction of antibody-dependent cellular cytotoxicity in the treatment of established B16 melanoma liver nodules

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

Incubation of C3H/Hen thymocytes in the presence of recombinant human tumor necrosis factor α (TNF) and interleukin-2 (IL-2) augmented the generation of antibody-dependent cellular cytotoxicity (ADCC) when compared to cells cultured in TNF or IL-2 alone. This effect was optimal when 100–200 units/ml IL-2 was used together with 103–104 units/ml TNF. TNF alone at any concentration could not mediate the induction of ADCC. Similar to the results obtained in vitro, TNF, when given alone, had no effect on the generation of ADCC in vivo. The addition, however, of TNF to IL-2, given at 10 000 and 20 000 but not 40 000 units, enhanced the IL-2-induced ADCC on a per-cell basis. Furthermore, TNF enhanced the total ADCC activity in various organs including the liver, spleen and thymus as a result of an increase in the number of mononuclear cells isolated from these organs. The increase in total ADCC activity was optimal when 110 000–220 000 units (5–10 µg) TNF were employed together with IL-2. The combined treatment with TNF and IL-2 also increased the intracellular benzyloxycarbonyl-l-l-lysinethiobenzyl-ester esterase content in cells isolated from the livers of mice treated with these cytokines. On the basis of these results we treated mice bearing a single B 16 melanoma nodule with TNF and TNF + IL-2 given with or without anti-B 16 monoclonal antibody. We found that TNF administration augmented the anti-tumor effect of specific anti-B 16 antibodies, and the addition of IL-2 further increased this anti-tumor effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Asher AL, Mule JJ, Reichert CM, Shiloni E, Rosenberg SA (1987) Studies of the antitumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J Immunol 138: 963

    PubMed  Google Scholar 

  2. Aguet M, Vignaux F, Fridman WH, Gresser I (1987) Enhancement of Fcγ receptor expression in interferon-treated mice. Eur J Immunol 11: 926

    Google Scholar 

  3. Balkwill FR, Lee A, Aldman G, Moodie E, Thomas A, Tavernier J, Fiers W (1986) Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res 46: 3990

    PubMed  Google Scholar 

  4. Creasy AA, Reynolds TR, Laird W (1986) Cures and partial regression of murine and human tumors by recombinant tumor necrosis factor. Cancer Res 46: 5687

    PubMed  Google Scholar 

  5. Eisenthal A, Rosenberg SA (1989) The effect of various cytokines on the in vitro induction of antibody-dependent cellular cytotoxicity in murine cells. Enhancement of IL-2 induced antibody-dependent cellular cytotoxicity activity by IL-1 and tumor necrosis factor-α. J Immunol 142: 2307

    PubMed  Google Scholar 

  6. Eisenthal A, Lafreniere R, Lefor AT, Rosenberg SA (1987) The effect of anti-B 16 melanoma monoclonal antibody on established murine B 16 melanoma liver metastases. Cancer Res 47: 2771

    PubMed  Google Scholar 

  7. Eisenthal A, Shiloni E, Rosenberg SA (1988) Characterization of IL-2 induced murine cells which exhibit ADCC activity. Cell Immunol 115: 257

    PubMed  Google Scholar 

  8. Ezekovirtz AB, Bampton M, Gordon S (1983) Macrophage activation selectively enhances expression of Fc receptors for IgG2a. J Exp Med 157: 807

    PubMed  Google Scholar 

  9. Gehan EA (1965) Generalized Wilcoxon test for comparing arbitrarily single censored samples. Biometrica 52: 203

    Google Scholar 

  10. Graziano FR, Franger MW (1987) Fc γRs and Fc γRII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells. J Immunol 139: 3536

    PubMed  Google Scholar 

  11. Handwerger BS, Koren HS (1976) The nature of the effector cell in antibody-dependent, cell mediated cytolysis (ADCC): the cytotoxic activity of murine cells and peritoneal macrophages. Clin Immunol Immunopathol 5: 272

    PubMed  Google Scholar 

  12. Henkart P, Yue CC (1988) The role of cytoplasmic granules in lymphocyte cytotoxicity. Prog Allergy 40: 82

    PubMed  Google Scholar 

  13. Hori K, Ehrke MJ, Mace K, Maccubbin D, Doyle MJ, Otsuka Y, Mihich E (1987) Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity. Cancer Res 47: 2793

    PubMed  Google Scholar 

  14. Hosnik C, Jung G, Reisfeld RA (1986) Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human effector cells of neuroectodermal origin. Proc Natl Acad Sci USA 83: 7893

    PubMed  Google Scholar 

  15. Huddlestone JR, Merigan TC, Oldstone MB (1979) Induction and kinetics of natural killer cells in humans following interferon therapy. Nature 282: 417

    PubMed  Google Scholar 

  16. Lopez AF, Nicola NA, Burgess AW, Metcalf D, Battye FL, Sewell WA, Vadas M (1983) Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol 131: 2983

    PubMed  Google Scholar 

  17. McIntosh JK, Mule JJ, Krosnick JA, Rosenberg SA (1989) Combination cytokine immunotherapy with tumor necrosis factor α, interleukin-2 and α-interferon and its synergistic antitumor effects in mice. Cancer Res 49: 1408

    PubMed  Google Scholar 

  18. Mule JJ, Krosnick JA, Rosenberg SA (1989) IL-4 reulgation of murine lymphokine-activated killer (LAK) activity in vitro. Effect on the interleukin-induced expansion, cytotoxicity and phenotype of LAK effectors. J Immunol 142: 726

    PubMed  Google Scholar 

  19. Munn DH, Cheung NKV (1987) Interleukin-2 enhancement of monoclonal antibody-mediated cellular cytotoxicity against human melanoma. Cancer Res 47: 6600

    PubMed  Google Scholar 

  20. Ortaldo JR, Woodhouse C, Morgan AC, Herberman RB, Cheresh DA, Reisfeld RA (1987) Analysis of effector cells in human antibody dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol 138: 3566

    PubMed  Google Scholar 

  21. Owen-Schaub LB, Gutterman JU, Grimm EA (1988) Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor α and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res 48: 788

    PubMed  Google Scholar 

  22. Pasternack MS, Verret CR, Liu MA, Eisen HN (1986) Serine esterase in cytolytic T lymphocytes. Nature 322: 740

    PubMed  Google Scholar 

  23. Philip R, Epstein LB (1986) Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature 323: 86

    PubMed  Google Scholar 

  24. Ralph P, Nakoinz I, Rennick D (1988) Role of interleukin 2, interleukin 4 and α, β and γ interferon in stimulating macrophage antibody-dependent tumoricidal activity. J Exp Med 167: 712

    PubMed  Google Scholar 

  25. Ruff MR, Gifford GE (1980) Purification and physico chemical characterization of rabbit tumor necrosis factor. J Immunol 125: 1671

    PubMed  Google Scholar 

  26. Sachs DH, Cone JL (1973) A murine B-cell aloantigen determined by gene(s) linked to the major histocompatbility complex. J Exp Med 138: 1289

    PubMed  Google Scholar 

  27. Santoni A, Herberman RB, Holden HT (1979) Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells. J Natl Cancer Inst 63: 995

    PubMed  Google Scholar 

  28. Scheurich P, Thomas B, Ucer U, Pfizemaier K (1987) Immunotrgulatory activity of recombinant human tumor necrosis factor (NF)-α: induction of TNF receptors on human T cells and TNf-α, mediated enhancement of T cell responses. J Immunol 138: 1786

    PubMed  Google Scholar 

  29. Shiloni E, Eisenthal A, Sachs D, Rosenberg SA (1987) Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin-2. J Immunol 138: 1992

    PubMed  Google Scholar 

  30. Titus JA, Finkelman FD, Stephany DA, Jones JF, Segal DM (1984) Quantitative analysis of Fc receptors on murine spleen cell populations by using dual parameter flow cytometry. J Immunol 133: 556

    PubMed  Google Scholar 

  31. Unkeles JC (1979) Characterization of a monoclonal antibody directed against mouse macrophages and lymphocyte Fc receptors. J Exp Med 150: 580

    PubMed  Google Scholar 

  32. Weiner LM, Steplewski Z, Koprowski H, Litwin S, Comis RL (1988) Divergent dose-related effects of gamma-interferon therapy on in vitro antibody-dependent cellular and non specific cytotoxicity by human peripheral blood monocytes. Cancer Res 48: 1042

    PubMed  Google Scholar 

  33. Wiltrout RH, Santoni A, Peterson ES, Knott DC, Overton WR, Herberman RB, Holden HT (1985) Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages. J Leukocyte Biol 37: 597

    PubMed  Google Scholar 

  34. Zagury D, Morgan DA, Fouchard M, Bernard J, Feldman M, Herberman RB (1985) Heterogeneity of human natural killer cell. J Natl Cancer Inst 74: 553

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgery Branch, National Cancer Institute, National Institutes of Health, 20892, Bethesda, MD, USA

    A. Eisenthal & J. K. McIntosh

Authors
  1. A. Eisenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. K. McIntosh
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Offprint requests to: S. A. Rosenberg, Surgery Branch, National Cancer Institute, Building 10, Room 2B42, Bethesda, MD 20892 USA

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisenthal, A., McIntosh, J.K. Effect of recombinant human tumor necrosis factor α on the induction of antibody-dependent cellular cytotoxicity in the treatment of established B16 melanoma liver nodules. Cancer Immunol Immunother 31, 243–249 (1990). https://doi.org/10.1007/BF01789176

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01789176

Keywords

Search

Navigation